SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 13 May 2021
Last Applicant/ Owned by
9715 Key West Avenue
Rockville
MD
20850
Serial Number
85644722 filed on 06th Jun 2012
Registration Number
4498773 registered on 18th Mar 2014
Correspondent Address
Mark D. Simpson
Mark D. Simpson Saul Ewing Arnstein & Lehr LLP
Centre Square West, 38th Floor
PHILADELPHIA, PA 19102-2100
United States
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
TROKENDI XR
Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
First Use Date in General
30th Sep 2013
First Use Date in Commerce
30th Sep 2013
Mark Details
Serial Number
No 85644722
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 356969.00029
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Jun 2024 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
| 18th Jun 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 18th Mar 2024 | TEAS SECTION 8 & 9 RECEIVED |
| 18th Mar 2023 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 13th May 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 13th May 2021 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 18th Nov 2020 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 11th Nov 2020 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
| 09th Nov 2020 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 09th May 2020 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |